Inspire Advisors’s Pediatrix Medical MD Stock Holding History

Inspire Advisors’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-16,440	Closed	-$275K	–	604
2025 Q3	$275K	Buy	+16,440	New	+$246K	0.03%	405

Other funds holding MD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Inspire Advisors's MD Position: Q4 2025 in Review

Inspire Advisors sold out of Pediatrix Medical (MD) in Q4 2025, closing a stake of 16,440 shares — an estimated $275K sold.

Inspire Advisors first reported a position in MD in Q3 2025 and held it in 1 quarter. The position peaked at $275K in Q3 2025. 299 funds tracked by Wall St. Rank hold MD as of Q4 2025.

Inspire Advisors reported no remaining Pediatrix Medical position as of Q4 2025 after selling out during the quarter.
Inspire Advisors sold 16,440 Pediatrix Medical shares in Q4 2025, an estimated $275K.
Inspire Advisors first reported a position in Pediatrix Medical in Q3 2025 and held it in 1 quarter.
Inspire Advisors's Pediatrix Medical position peaked at $275K in Q3 2025.
299 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2025.

Based on Inspire Advisors's 13F filing for Q4 2025, filed 13 Feb 2026.